The CGIAR is the leading global agriculture research institution working towards creating sustainable agricultural practices a reality through research and innovation. The CGIAR 2030

To meet the growing demand for food in the Global South in a sustainable manner, current funding in agricultural innovation will need to be increased exponentially. Some estimates suggest up to USD 320 billion annually is required to help meet the UN SDG Goals for food and agriculture by 2030. Current levels of funding for agriculture and agricultural innovation fall far short of this and hence efforts to induce more funding for these goals, including through the use of new financing instruments1, is critical going forward.

The only specialized multilateral development institution focused exclusively on rural development, IFAD has successfully used agriculture as a means of poverty reduction – contributing ~USD 22 billion in funding to date1. About 90% of IFAD's portfolio is focused on Low to Middle Income (LMI) countries. IFAD stands out with its nutrition and gender-sensitive lenses coupled with investments in climate-resilient agriculture – mainstreaming nutrition, gender, and climate change work in agriculture.

This paper discusses innovation in low and middle-income countries, focusing on the role it has played in local and national responses to the COVID-19 pandemic, and the lessons from this effort for how innovation might be harnessed to address wider development and humanitarian challenges by mobilising resources, improving processes, catalysing collaboration and encouraging creative and contextually grounded approaches. The paper also examines how international development and humanitarian organisations can improve their support for local and national innovation efforts.

One-fifth of the innovative solutions to fight the Covid-19 pandemic have emerged from low and middle-income countries, and these responses offer promising insights for how we think about, manage, and enable innovation. As the international community now faces the historic challenge of vaccinating the world, more attention and resources must be directed to the innovators who are developing technically novel, contextually relevant, and socially inclusive alternatives to mainstream innovation management practices.